| scholarly article | Q13442814 |
| P50 | author | Izolde Bouloukaki | Q88829217 |
| Charalampos Mermigkis | Q88829219 | ||
| Sophia E Schiza | Q88829221 | ||
| P2093 | author name string | Nikolaos Tzanakis | |
| Eleni Mauroudi | |||
| Violeta Moniaki | |||
| Eleftherios Kallergis | |||
| P2860 | cites work | Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein | Q27003309 |
| Biomarkers associated with obstructive sleep apnea: A scoping review | Q28082137 | ||
| Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death | Q28193124 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk | Q28300313 | ||
| Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample | Q28534287 | ||
| The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome | Q33658835 | ||
| Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? | Q33984737 | ||
| Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Counc | Q34013511 | ||
| Obstructive sleep apnea as a risk factor for stroke and death | Q34466726 | ||
| Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. | Q34697479 | ||
| Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients | Q35258706 | ||
| Epidemiological aspects of obstructive sleep apnea. | Q35681064 | ||
| C-reactive protein is associated with sleep disordered breathing independent of adiposity | Q35995463 | ||
| Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. | Q35995551 | ||
| OSA and atherosclerosis | Q36042326 | ||
| Biomarkers of sleep apnea | Q36163526 | ||
| Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more | Q36482623 | ||
| Vascular inflammation and sleep disordered breathing in a community-based cohort | Q36755615 | ||
| Obstructive sleep apnea, cardiovascular disease, and inflammation--is NF-kappaB the key? | Q36767636 | ||
| Increased prevalence of sleep-disordered breathing in adults | Q36805068 | ||
| C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus | Q36832818 | ||
| C-reactive protein, fibrinogen, and cardiovascular disease prediction | Q37021409 | ||
| Serum inflammatory markers in obstructive sleep apnea: a meta-analysis | Q37185423 | ||
| Association of sleep-disordered breathing and the occurrence of stroke | Q37282690 | ||
| A Relationship between the Obstructive Sleep Apnea Syndrome and the Erythrocyte Sedimentation Rate | Q37362661 | ||
| Obstructive sleep apnea and inflammation | Q37403206 | ||
| Obstructive sleep apnea, immuno-inflammation, and atherosclerosis | Q37464853 | ||
| Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity | Q37857963 | ||
| C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 | ||
| Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. | Q43103931 | ||
| Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia | Q43747202 | ||
| Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine | Q44212481 | ||
| Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality | Q44376036 | ||
| Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. | Q44379232 | ||
| Hyperuricaemia in males with obstructive sleep apnoea (osa) | Q44408302 | ||
| Influence of gender on C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in obstructive sleep apnea | Q44906990 | ||
| CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role? | Q45115317 | ||
| Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. | Q46402843 | ||
| Blood biomarkers of endocrine, immune, inflammatory, and metabolic systems in obstructive sleep apnea | Q47856758 | ||
| Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea | Q48023504 | ||
| Comprehensive biomarker profiling in patients with obstructive sleep apnea. | Q48030463 | ||
| Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome | Q48109261 | ||
| Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia? | Q48270229 | ||
| The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea | Q48316328 | ||
| Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome | Q48455753 | ||
| Sleep-disordered breathing and uric acid in overweight and obese children and adolescents | Q48469020 | ||
| Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome | Q48516715 | ||
| Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome | Q48525924 | ||
| Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk | Q48544900 | ||
| Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure | Q48634373 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
| Fibrinogen levels and obstructive sleep apnea in ischemic stroke | Q48708426 | ||
| Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik Study | Q57267225 | ||
| Obstructive Sleep Apnea and Atherosclerosis | Q61386195 | ||
| Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study | Q74637821 | ||
| [Blood uric acid levels in patients with sleep-disordered breathing] | Q79305352 | ||
| [Hyperuricaemia in females with obstructive sleep apnoea] | Q79704899 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | comorbidity | Q1414874 |
| obstructive sleep apnea | Q16606552 | ||
| P304 | page(s) | 4573756 | |
| P577 | publication date | 2017-07-31 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities | |
| P478 | volume | 2017 |
| Q64859151 | Androgens modulate chronic intermittent hypoxia effects on brain and behavior |
| Q87866404 | Antero-cervical thermophysiological characterization of obstructive sleep apnea patients |
| Q49300818 | Intermittent hypoxia, cardiovascular disease and obstructive sleep apnoea |
| Q89628492 | Obstructive Sleep Apnea Is Associated with Newly-Diagnosed Gestational Diabetes Mellitus |
| Q64277457 | Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines |
| Q90282093 | Periodontal disease, sleep duration, and white blood cell markers in the 2009 to 2014 National Health and Nutrition Examination Surveys |
| Q90177555 | Predictors of chronic kidney disease in obstructive sleep apnea patients |
| Q90292278 | Relationship between monocyte to HDL cholesterol ratio and concomitant cardiovascular disease in Chinese Han patients with obstructive sleep apnea |
| Q91690317 | Serum Uric Acid Is Independently Associated with Risk of Obstructive Sleep Apnea-Hypopnea Syndrome in Chinese Patients with Type 2 Diabetes |
| Q47652448 | Sex differences in sleep apnea and comorbid neurodegenerative diseases. |
| Q98186313 | The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome |
Search more.